21
Participants
Start Date
July 1, 2019
Primary Completion Date
February 7, 2025
Study Completion Date
February 7, 2025
Rituximab
Rituximab 375mg/m2 intravenous on day 0 or -1 prior to kidney transplant
Plasmapheresis
1.5 volume exchange plasmapheresis with fresh frozen plasma replacement
Children's Hospital of Philadelphia, Philadelphia
Duke University, Durham
University of Alabama, Tuscaloosa
University of Cincinnati, Cincinnati
Cincinnati Children's Hospital, Cincinnati
University of Iowa, Iowa City
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
Lurie Children's Hospital, Chicago
Children's Hospital of Colorado, Aurora
University of California at Davis, Davis
Seattle Children's Hospital, Seattle
United States Department of Defense
FED
University of Minnesota
OTHER